Migraine Newswire (Page 6)

Migraine Newswire (Page 6)

Comprehensive Real-Time News Feed for Migraine. (Page 6)

Results 101 - 120 of 1,134 in Migraine

  1. From virtual to clinical: The discovery of PGN-1531, a novel...Read the original story

    May 11, 2016 | CiteULike

    ... is a potent and selective antagonist at EP4Rs in vitro and in vivo, with the potential to alleviate the symptoms of migraine that result from cerebral vasodilatation. Copyright A 2014 Elsevier Ltd. All rights reserved.

    Comment?

  2. UPDATE 1-U.S. probes contracts between drugmakers, pharmacy benefit managersRead the original story w/Photo

    May 10, 2016 | Reuters

    ... received a demand for information about contracts with, services from and payments made to PBMs in relation to its migraine drug, Maxalt, and erectile dysfunction treatment Levitra, over the same period. ( 1.usa.gov/1T4gEHV ) Endo said last week it ...

    Comment?

  3. U.S. probes contracts between drugmakers, pharmacy benefit managersRead the original story

    May 10, 2016 | Reuters

    ... received a demand for information about contracts with, services from and payments made to PBMs in relation to its migraine drug, Maxalt, and erectile dysfunction treatment Levitra, over the same period. ( 1.usa.gov/1T4gEHV ) Endo said last week it ...

    Comment?

  4. Pain Management Drugs Market Analysis, Development, Growth and Demand Forecast to 2020Read the original story w/Photo

    May 10, 2016 | PR Log

    May 10, 2016 - PRLog -- The growing geriatric population and increasing demand of innovative and advanced pain relaxing medications around the world are the predominant growth drivers for the global pain management drugs market Drugs By Therapeutic Indications O Post-Operative Pain O Low-Back Pain O Rheumatoid Arthritis Pain O Osteoarthritis Pain O Cancer Pain O Migraine O Neuropathic Pain O Fibromyalgia O Others By Brands O Maxalt O Zomig O Qutenza O Lidoderm O Savella O Imitrex O Voltaren Gel O Celebrex O Cymbalta O Others By Geography O North America o U.S. o Canada O Europe o Germany o France o U.K. o Spain o Italy O Asia o Japan o China o India O Latin America o Brazil O Rest of the World About P&S Market Research P&S Market Research is a global market research and consulting company.

    Comment?

  5. ACETO's (ACET) CEO Salvatore Guccione on Q3 2016 Results - Earnings Call TranscriptRead the original story w/Photo

    May 6, 2016 | Seeking Alpha

    Welcome to the ACETO Fiscal 2016 Third Quarter Financial Results Conference Call. My name is John, and I'll be your operator for today's call.

    Comment?

  6. Mayo Clinic to Receive $7 Million Research Funding Award for Migraine ...Read the original story

    May 4, 2016 | Newswise

    A Mayo Clinic research team, led by neurologists Todd Schwedt, M.D. and David Dodick, M.D., has been approved for $7 million in funding from the Patient-Centered Outcomes Research Institute to study migraine treatment strategies. MULTIMEDIA ALERT: Video and audio are available for download on the Mayo Clinic News Network.

    Comment?

  7. Looking For Anxiety Relief? 'Power Breath' Exercises Produce...Read the original story w/Photo

    May 4, 2016 | Medical Daily

    ... to enhance the "calm-and-collected" state which has been used effectively by people to stop a panic attack, reduce migraine symptoms, and for dealing with muscle spasms or muscle cramps. Power breath allows our body to switch into a calm-connected ...

    Comment?

  8. Global Migraine Market and Competitive Landscape Report 2016 - Research and MarketsRead the original story w/Photo

    May 4, 2016 | PR Newswire

    Global Migraine Market and Competitive Landscape Highlights 2016, provides comprehensive insights into Migraine pipeline products, Migraine epidemiology, Migraine market valuations and forecast, Migraine products and competitive landscape. This report is classified into eleven sections - Migraine overview including etiology, pathophysiology, and diagnosis, Migraine treatment options, Migraine pipeline products, Migraine market analysis globally and by each country.

    Comment?

  9. Zacks Investment Research Downgrades Vernalis plc (VNLPY) to SellRead the original story w/Photo

    May 3, 2016 | Daily Political

    ... products: Tuzistra XR in the United States prescription cough cold market, and frovatriptan, an acute treatment for migraine. Receive News & Ratings for Vernalis plc Daily - Enter your email address below to receive a concise daily summary of the ...

    Comment?

  10. Zacks Investment Research Downgrades RedHill Biopharma Ltd - (RDHL) to SellRead the original story w/Photo

    May 3, 2016 | Daily Political

    According to Zacks, "RedHill Biopharma is an Israeli biopharmaceutical company primarily focused on the development and commercialization of late clinical-stage, proprietary, orally-administered, small molecule drugs for inflammatory and gastrointestinal diseases, including cancer.

    Comment?

  11. Magnesium: Migraine Miracle Cure?Read the original story w/Photo

    May 2, 2016 | News Max

    Magnesium has the potential to stop, or greatly lessen, the excruciating pain and accompanying symptoms of migraines, without the harsh side effects of prescription drugs. Could this be a miracle cure? According to the University of Maryland Medical Center , the exact cause of migraines is not completely known; however, it is believed that during a migraine the blood vessels in the brain dilate, increasing the amount of blood flow, in addition to causing chemical and nerve changes.

    Comment?

  12. Vernalis plc (VNLPY) Lowered to Sell at Zacks Investment ResearchRead the original story w/Photo

    Apr 27, 2016 | AmericanBankingNews.com

    ... products: Tuzistra XR in the United States prescription cough cold market, and frovatriptan, an acute treatment for migraine. This story was originally published by American Banking News (http://www.americanbankingnews.com) and is the sole property ...

    Comment?

  13. Depomed gives Starboard chance for meeting to replace boardRead the original story w/Photo

    Apr 25, 2016 | Post-Bulletin

    ... value. Newark, California-based Depomed, whose product portfolio includes the painkiller Nucynta and the migraine drug Cambia, has said that its board is focused on creating value for all shareholders. Starboard has been particularly incensed by a ...

    Comment?

  14. Reed Migraine Centers To Host Dallas Seminar on Advanced Neurostimulation Migraine Treatment OptionsRead the original story w/Photo

    Apr 25, 2016 | PRWeb

    Inventors of the award-winning Reed and Omega Neurostimulation Procedures to present a patient information seminar on advanced migraine treatment options, including peripheral nerve stimulation therapies in Dallas, TX, on April 28th. Reed Migraine Centers will host a patient information seminar on advanced neurostimulation migraine treatments in Dallas, TX on April 28th at 6:30pm.

    Comment?

  15. Shore Capital Reiterates "house stock" Rating for Vernalis plcRead the original story w/Photo

    Apr 23, 2016 | AmericanBankingNews.com

    ... products: Tuzistra XR in the United States prescription cough cold market, and frovatriptan, an acute treatment for migraine. This story was originally published by American Banking News (http://www.americanbankingnews.com) and is the sole property ...

    Comment?

  16. Migraine Treatment is Discussed with James Earl Jones on 'Behind The Scenes' for Public TelevisionRead the original story

    Apr 23, 2016 | PRWeb

    A group of doctors and neurological experts will discuss the latest in migraine treatment in an upcoming issue of Behind the Scenes with James Earl Jones. The short film will talk about causes of migraine headaches, and the latest technology in the treatment of the disorder.

    Comment?

  17. "Pink tax" and contraception bills advanced yesterdayRead the original story

    Apr 22, 2016 | The Capitol Fax Blog

    ... female lawmakers arguing birth control could be used for means other than pregnancy prevention, such as treating migraine headaches or regulating menstrual cycles. Say what you want. It's a free country. But a guy running for reelection in a swing ...

    Comment?

  18. Vernalis plc (VER) Stock Rating Reaffirmed by Shore CapitalRead the original story w/Photo

    Apr 22, 2016 | AmericanBankingNews.com

    ... products: Tuzistra XR in the United States prescription cough cold market, and frovatriptan, an acute treatment for migraine. This story was originally published by American Banking News (http://www.americanbankingnews.com) and is the sole property ...

    Comment?

  19. Nexeon MedSystems, Inc. Announces Acquisition Of Neuromodulation IP...Read the original story

    Apr 21, 2016 | BioSpace

    NeuroTek was founded by inventor and neuroengineer Alejandro Covalin, PhD, and was a 2013 graduate of the Health Wildcatters program, a mentor-driven seed accelerator focused on improving healthcare. The NeuroTek portfolio includes innovations related to electrode design and occipital nerve stimulation for the treatment of migraine headaches.

    Comment?

  20. Nexeon MedSystems Announces Acquisition of Neuromodulation IP from...Read the original story

    Apr 21, 2016 | Freshnews

    ... portfolio includes innovations related to electrode design and occipital nerve stimulation for the treatment of migraine headaches. Nexeon has existing research programs using similar technology to treat cardiovascular disease, cognitive ...

    Comment?